Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005184 |
---|---|
Receipt number | R000006155 |
Scientific Title | Clinical efficacy and biomarker assessment of Capecitabine plus oxaliplatin (XELOX) in combination with Bevacizumab as second-line therapy in patients with advanced or recurrent colorectal cancer after failure to irinotecan. Multi-center phase II Study. |
Date of disclosure of the study information | 2011/03/03 |
Last modified on | 2019/09/17 17:42:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/03/03 17:23:21 | ||
2 | Update | 2015/03/11 11:17:47 | Email Last name of contact person Last name of contact person Name of person sending information Name of person sending information Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2015/03/11 12:24:15 | Last follow-up date |
|
4 | Update | 2019/09/17 17:42:53 | Recruitment status Date of IRB |